Cullinan Associates’s Amcor AMCR Stock Holding History

Cullinan Associates’s Portfolio AMCR Stock Details AMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,592	Closed	-$393K	–	245
2022 Q4	$393K	Buy	+6,592	New	+$384K	0.02%	222

Other funds holding AMCR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Cullinan Associates's AMCR Position: Q1 2023 in Review

Cullinan Associates sold out of Amcor (AMCR) in Q1 2023, closing a stake of 6,592 shares — an estimated $393K sold.

Cullinan Associates first reported a position in AMCR in Q4 2022 and held it in 1 quarter. The position peaked at $393K in Q4 2022. 572 funds tracked by Wall St. Rank hold AMCR as of Q1 2023.

Cullinan Associates reported no remaining Amcor position as of Q1 2023 after selling out during the quarter.
Cullinan Associates sold 6,592 Amcor shares in Q1 2023, an estimated $393K.
Cullinan Associates first reported a position in Amcor in Q4 2022 and held it in 1 quarter.
Cullinan Associates's Amcor position peaked at $393K in Q4 2022.
572 funds tracked by Wall St. Rank held Amcor as of Q1 2023.

Based on Cullinan Associates's 13F filing for Q1 2023, filed 5 Apr 2023.